Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 21;44(1):29-54.
doi: 10.1093/epirev/mxac003.

A Review of the Ring Trial Design for Evaluating Ring Interventions for Infectious Diseases

A Review of the Ring Trial Design for Evaluating Ring Interventions for Infectious Diseases

Zachary Butzin-Dozier et al. Epidemiol Rev. .

Abstract

In trials of infectious disease interventions, rare outcomes and unpredictable spatiotemporal variation can introduce bias, reduce statistical power, and prevent conclusive inferences. Spillover effects can complicate inference if individual randomization is used to gain efficiency. Ring trials are a type of cluster-randomized trial that may increase efficiency and minimize bias, particularly in emergency and elimination settings with strong clustering of infection. They can be used to evaluate ring interventions, which are delivered to individuals in proximity to or contact with index cases. We conducted a systematic review of ring trials, compare them with other trial designs for evaluating ring interventions, and describe strengths and weaknesses of each design. Of 849 articles and 322 protocols screened, we identified 26 ring trials, 15 cluster-randomized trials, 5 trials that randomized households or individuals within rings, and 1 individually randomized trial. The most common interventions were postexposure prophylaxis (n = 23) and focal mass drug administration and screening and treatment (n = 7). Ring trials require robust surveillance systems and contact tracing for directly transmitted diseases. For rare diseases with strong spatiotemporal clustering, they may have higher efficiency and internal validity than cluster-randomized designs, in part because they ensure that no clusters are excluded from analysis due to zero cluster incidence. Though more research is needed to compare them with other types of trials, ring trials hold promise as a design that can increase trial speed and efficiency while reducing bias.

Keywords: disease elimination; emerging infections; postexposure prophylaxis; randomized controlled trials; reactive interventions; ring trials; ring vaccination; targeted interventions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram for systematic review screening and inclusion. All registrations from ClinicalTrials.gov were reviewed in a single stage of full-text review, and records overlapped. “Total included studies” refers to research projects for which 1 or more records were included. Records of studies include trial registrations, published trial protocols, and original research articles.
Figure 2
Figure 2
Types of ring intervention trial designs. A) Ring trial design. B) Ring-stratified randomized trial. C) Cluster-randomized trial of ring intervention. The dotted line separates cluster 1 (left) from cluster 2 (right). Whereas all participants in cluster 1 were assigned to the intervention group, only participants inside the 4 rings received the intervention.

Similar articles

Cited by

References

    1. Woolhouse ME, Dye C, Etard JF, et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A. 1997;94(1):338–342. - PMC - PubMed
    1. Lipsitch M, Eyal N. Improving vaccine trials in infectious disease emergencies. Science. 2017;357(6347):153–156. - PMC - PubMed
    1. Cotter C, Sturrock HJW, Hsiang MS, et al. The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet. 2013;382(9895):900–911. - PMC - PubMed
    1. Foege WH, Millar JD, Lane JM. Selective epidemiologic control in smallpox eradication. Am J Epidemiol. 1971;94(4):311–315. - PubMed
    1. Corbett MS, Higgins JPT, Woolacott NF. Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool. Res Synth Methods. 2014;5(1):79–85. - PubMed

Publication types